En-tête de navigationNavigation principaleSuiviFiche


Unité de recherche
INNOSUISSE
Numéro de projet
13541.1;5 PFFLR-LS
Titre du projet
Discovery of an activity modulating humanized antibody towards a voltage-gated sodium channel for the therapy of chronic severe pain
Titre du projet anglais
Discovery of an activity modulating humanized antibody towards a voltage-gated sodium channel for the therapy of chronic severe pain

Textes relatifs à ce projet

 AllemandFrançaisItalienAnglais
Description succincte
Anzeigen
-
-
Anzeigen
Résumé des résultats (Abstract)
Anzeigen
-
-
Anzeigen

Textes saisis


CatégorieTexte
Description succincte
(Allemand)
Discovery of an activity modulating humanized antibody towards a voltage-gated sodium channel for the therapy of chronic severe pain
Description succincte
(Anglais)
Discovery of an activity modulating humanized antibody towards a voltage-gated sodium channel for the therapy of chronic severe pain
Résumé des résultats (Abstract)
(Allemand)
The aim of this project is the discovery of a novel and innovative product for the treatment of chronic severe pain. The anticipated product candidate will specifically block pain sensation without the oftentimes treatment limiting adverse effects of currently marketed products. To achieve this, a breakthrough antibody discovery technology shall be applied. Methods developed in this first part of the project shall be synergistically used for the discovery of a second antibody specifically targeting breast cancer metastasis.
Résumé des résultats (Abstract)
(Anglais)
The aim of this project is the discovery of a novel and innovative product for the treatment of chronic severe pain. The anticipated product candidate will specifically block pain sensation without the oftentimes treatment limiting adverse effects of currently marketed products. To achieve this, a breakthrough antibody discovery technology shall be applied. Methods developed in this first part of the project shall be synergistically used for the discovery of a second antibody specifically targeting breast cancer metastasis.